Central Asia’s First Biothreat Research Lab to Play Threat-Reduction Role

None

Rachel Oswald, Global Security Newswire
Aug. 9, 2013, 9:02 a.m.

SE­MEY, Kaza­kh­stan — A state-of-the-art med­ic­al re­search labor­at­ory is un­der con­struc­tion in a sub­urb of Al­maty, Kaza­kh­stan’s busi­ness cap­it­al, us­ing U.S. funds aimed at help­ing re­ori­ent former bio­lo­gic­al weapons-re­lated re­search un­der the So­viet Uni­on to peace­ful pub­lic health uses, ac­cord­ing to of­fi­cials in­volved with the pro­ject.

When it opens in 2015, the Cent­ral Ref­er­ence Labor­at­ory is ex­pec­ted to fo­cus on some of the world’s most dan­ger­ous emer­ging patho­gens with sup­port from the Nunn-Lugar Co­oper­at­ive Threat Re­duc­tion Pro­gram, draw­ing off of years of U.S. and Kaza­kh­stani joint co­oper­a­tion.

“We’re go­ing to have here the most up-to-date equip­ment,” said B.B. Atshabar, dir­ect­or of the Kaza­kh­stan Sci­entif­ic Cen­ter for Quar­ant­ine and Zo­onot­ic Dis­eases, speak­ing through a trans­lat­or to a group of U.S. journ­al­ists who vis­ited the con­struc­tion site of the new labor­at­ory on Tues­day.

Once fin­ished, the planned 87,000 square-foot labor­at­ory is slated to be the first of its kind in Cent­ral Asia to in­clude re­search areas that meet in­ter­na­tion­ally re­cog­nized Biosafety Level-3 stand­ards, which in­volve spe­cial en­gin­eer­ing, design and staff-train­ing pro­to­cols in­ten­ded to min­im­ize the risks of work­ing with po­ten­tially deadly dis­ease agents, such as an­thrax and plague. Yet more of the lab space, though, will be de­voted to Biosafety Level-2 work in­volving the study of patho­gens that pose mod­er­ate health haz­ards.

“The ul­ti­mate goal of the labor­at­ory will be its in­ter­na­tion­al ac­cred­it­a­tion,” Atshabar said. “The res­ults that will be achieved in this labor­at­ory will be open to all of the world” to util­ize, he said.

The fo­cus of work at the fu­ture fa­cil­ity will be on de­vel­op­ing im­proved dia­gnost­ic tools and coun­ter­meas­ures for patho­gens that af­fect both hu­mans and an­im­als. The labor­at­ory is also ex­pec­ted to aid neigh­bor­ing Cent­ral Asi­an states in dia­gnos­ing and con­trolling the spread of new dis­ease strains, he said.

An­thrax and plague are en­dem­ic to Kaza­kh­stan and have been pub­lic health con­cerns here for some time. Kaza­kh­stani sci­ent­ists have de­veloped con­sid­er­able ex­pert­ise in­to these patho­gens but their re­search up un­til now has taken place in loc­al labor­at­or­ies that lack the in­ter­na­tion­ally re­cog­nized BSL-3 stand­ards, ac­cord­ing to Atshabar.

Un­der the So­viet Uni­on, “there wasn’t really a no­tion of peer-re­viewed sci­ence or trans­par­ency at all. Most of what they did was very tightly clas­si­fied and they had a lot of over­lap with the mil­it­ary,” said Phil Starling, the pro­gram dir­ect­or for sci­ence en­gage­ment at CRDF Glob­al, a non­profit that works on Co­oper­at­ive Threat Re­duc­tion pro­grams in Kaza­kh­stan and else­where un­der con­tract with the U.S. gov­ern­ment. Stand­ard prac­tice at that time was for sci­ent­ists in Kaza­kh­stan identi­fy­ing new strains of plague, for ex­ample, to send samples back to Mo­scow where they would be ex­amined and stud­ied spe­cific­ally for po­ten­tial ap­plic­a­tion as bio­lo­gic­al weapons, he said.

Kaza­kh­stan be­came an in­de­pend­ent na­tion in Decem­ber 1991, fol­low­ing the dis­sol­u­tion of the So­viet Uni­on.

Through the CTR pro­gram, the United States has worked to steer Kaza­kh­stani sci­ent­ists with a back­ground in dis­eases such as plague and an­thrax to non­mil­it­ary re­search that is trans­par­ent and pub­lished un­der the prin­ciples of glob­al sci­ence, said Starling. He was in­ter­viewed by phone in the United States late last month.

“A big part of the re­ori­ent­a­tion was in­tro­du­cing [Kaza­kh­stani sci­ent­ists] to the prin­ciples of west­ern [glob­al] sci­ence,” he said. “You get fund­ing based on the rig­or of your re­search and the valid­ity of your re­search, not ne­ces­sar­ily oth­er polit­ic­al pri­or­it­ies,” he said.

An­oth­er as­pect of CTR work in Kaza­kh­stan is find­ing em­ploy­ment for those sci­ent­ists with back­grounds in bio­lo­gic­al-weapon re­lated re­search, so that they will not be temp­ted to sell their ex­pert­ise to ter­ror­ists or rogue na­tions.

“We’ve done our best to em­ploy these people who have this know­ledge. It’s one of these chal­lenges that you can­not erase this know­ledge from someone’s mind,” said Lt. Col. Charles Carlton, dir­ect­or of the U.S. De­fense Threat Re­duc­tion Of­fice in Kaza­kh­stan.

“I do think that through our ef­forts, through U.S. fund­ing, Kaza­kh­stani fund­ing, we are do­ing our best to em­ploy these people,” he said on Tues­day to re­port­ers on a trip or­gan­ized by the In­ter­na­tion­al Re­port­ing Pro­ject.

Fund­ing for the $100 mil­lion con­struc­tion of the Cent­ral Ref­er­ence Labor­at­ory is com­ing en­tirely from the United States. Once it is up and run­ning, Wash­ing­ton each year will gradu­ally re­duce the amount of funds it provides to Kaza­kh­stan to op­er­ate the sci­entif­ic fa­cil­ity, un­til the gov­ern­ment in As­tana is fully un­der­writ­ing the labor­at­ory, Carlton said.

The CRL fa­cil­ity will con­tain 5,400 square feet of BSL-3 re­search space, ac­cord­ing to Dan Erbach, the site con­struc­tion man­ager for AE­COM, the com­pany build­ing the fa­cil­ity.

The U.S. gov­ern­ment is also provid­ing ap­prox­im­ately $5.6 mil­lion to build a sep­ar­ate site fea­tur­ing BSL-3 labor­at­ory space in the vil­lage of Otar in Kaza­kh­stan’s Zhambyl­skaya re­gion. The fa­cil­ity is in­ten­ded to provide an early warn­ing of any new dis­ease out­breaks that oc­cur in the re­gion and is in­ten­ded to com­ple­ment rather than du­plic­ate the work done at the Cent­ral Ref­er­ence Labor­at­ory in Al­maty, Carlton said. The Otar fa­cil­ity is ex­pec­ted to be com­pleted next April.

What We're Following See More »
TAKING A LONG VIEW TO SOUTHERN STATES
In Dropout Speech, Santorum Endorses Rubio
2 days ago
THE DETAILS

As expected after earlier reports on Wednesday, Rick Santorum ended his presidential bid. But less expected: he threw his support to Marco Rubio. After noting he spoke with Rubio the day before for an hour, he said, “Someone who has a real understanding of the threat of ISIS, real understanding of the threat of fundamentalist Islam, and has experience, one of the things I wanted was someone who has experience in this area, and that’s why we decided to support Marco Rubio.” It doesn’t figure to help Rubio much in New Hampshire, but the Santorum nod could pay dividends down the road in southern states.

Source:
‘PITTING PEOPLE AGAINST EACH OTHER’
Rubio, Trump Question Obama’s Mosque Visit
2 days ago
WHY WE CARE

President Obama’s decision to visit a mosque in Baltimore today was never going to be completely uncontroversial. And Donald Trump and Marco Rubio proved it. “Maybe he feels comfortable there,” Trump told interviewer Greta van Susteren on Fox News. “There are a lot of places he can go, and he chose a mosque.” And in New Hampshire, Rubio said of Obama, “Always pitting people against each other. Always. Look at today – he gave a speech at a mosque. Oh, you know, basically implying that America is discriminating against Muslims.”

Source:
THE TIME IS NOW, TED
Cruz Must Max Out on Evangelical Support through Early March
2 days ago
WHY WE CARE

For Ted Cruz, a strong showing in New Hampshire would be nice, but not necessary. That’s because evangelical voters only make up 21% of the Granite State’s population. “But from the February 20 South Carolina primary through March 15, there are nine states (South Carolina, Alabama, Arkansas, Georgia, Oklahoma, Tennessee, Kentucky, Mississippi, and North Carolina) with an estimated white-Evangelical percentage of the GOP electorate over 60 percent, and another four (Texas, Kansas, Louisiana, and Missouri) that come in over 50 percent.” But after that, he better be in the catbird’s seat, because only four smaller states remain with evangelical voter majorities.

Source:
CHRISTIE, BUSH TRYING TO TAKE HIM DOWN
Rubio Now Winning the ‘Endorsement Primary’
2 days ago
WHY WE CARE

Since his strong third-place finish in Iowa, Marco Rubio has won endorsement by two sitting senators and two congressmen, putting him in the lead for the first time of FiveThirtyEight‘s Endorsement Tracker. “Some politicians had put early support behind Jeb Bush — he had led [their] list since August — but since January the only new endorsement he has received was from former presidential candidate Sen. Lindsey Graham.” Meanwhile, the New York Times reports that fueled by resentment, “members of the Bush and Christie campaigns have communicated about their mutual desire to halt … Rubio’s rise in the polls.”

Source:
ARE YOU THE GATEKEEPER?
Sanders: Obama Is a Progressive
1 days ago
THE LATEST

“Do I think President Obama is a progressive? Yeah, I do,” said Bernie Sanders, in response to a direct question in tonight’s debate. “I think they’ve done a great job.” But Hillary Clinton wasn’t content to sit out the latest chapter in the great debate over the definition of progressivism. “In your definition, with you being the gatekeeper of progressivism, I don’t think anyone else fits that definition,” she told Sanders.

×